Skip to main content
. 2020 Mar 21;12(3):282. doi: 10.3390/pharmaceutics12030282

Table 3.

The composition and type of the vesicles investigated in the study.

Formulation ID Description Wt (mg)/100 mL
PC 1 MX 2 (0.08%) Cholesterol 3 (0.04%) CPC 4 (0.10%)
F1 Conventional Liposome 400/800/1200 80 - -
F2 Conventional Liposome 400/800/1200 80 40 -
F3 Transfersome 400/800/1200 80 40 100

1 Phosphatidylcholine, 2 Meloxicam, 3 Cholesterol, 4 Cetylpyridinium chloride.